Narcolepsy: all 152 studies
Page 1 of 2. Open to participants first (32), then studies with results posted, then the rest; newest registration first within each.
- Hypersomnia in the Paediatric PopulationNot yet recruitingNCT07766343Not applicable
- A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With NarcolepsyRecruitingNCT07675135Phase 3
- A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)RecruitingNCT07633301Phase 2
- A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IHRecruitingNCT07625280Phase 3
- A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have NarcolepsyRecruitingNCT07613710Phase 1
- A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of HypersomnolenceRecruitingNCT07598708Phase 2/3
- A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE)RecruitingNCT07540364Phase 3
- A Study to Evaluate the Efficacy and Safety of E2086 in Adults With NarcolepsyRecruitingNCT07493265Phase 2
- A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1RecruitingNCT07455383Phase 3
- A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic HypersomniaRecruitingNCT07096674Phase 2
- A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic HypersomniaRecruitingNCT07006233Not applicable
- Extended-release Sodium Oxybate in ChildrenRecruitingNCT06809803Phase 2
- The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake DisordersRecruitingNCT06797284Not applicable
- Genetic and Clinical Characterization of Type 1 and 2 Narcolepsy in Adult and Pediatric Black and North African PopulationsNot yet recruitingNCT06786377
- A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic HypersomniaRecruitingNCT06767683Phase 2/3
- Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM IntrusionsRecruitingNCT06457945Not applicable
- SUNOSI® (Solriamfetol) Pregnancy RegistryRecruitingNCT06413420
- Decreasing Nightmares in Adults With NarcolepsyRecruitingNCT06383806Not applicable
- Mentalizating in Adults Suffering from Narcolepsy Type 1.RecruitingNCT06336057
- Proteomics and Metabolomics of Body Fluid in Patients With NarcolepsyRecruitingNCT06279247
- A Pilot Observational Study to Assess the Ability of Continuous 'Home' EEG to Accurately Diagnose Narcolepsy and Demonstrate Response to TreatmentNot yet recruitingNCT05983731
- A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1Not yet recruitingNCT05914194Phase 3
- Treating Comorbid Depression of Patients With Narcolepsy by Intermittent Theta Burst StimulationRecruitingNCT05884112Not applicable
- Discovering Factors in Narcolepsy Patients' Clinical Research ExperiencesNot yet recruitingNCT05870735
- Evaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic HypersomniaRecruitingNCT05773872Not applicable
- WAKIX® (Pitolisant) Pregnancy RegistryRecruitingNCT05536011
- Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their TreatmentsEnrolling by invitationNCT05371483
- Mainz Register of Patients With Sleep DisordersRecruitingNCT05321355
- The Value of Combined Detection of Orexin-A, HLA Gene, PSG and MSLT in the Evaluation of Patients With NarcolepsyEnrolling by invitationNCT04940806
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruitingNCT04806620
- International Swiss Primary Hypersomnolence and Narcolepsy Cohort StudyRecruitingNCT04330963
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT01793168
- Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)TerminatedNCT06179407Phase 1Results posted
- A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or NarcolepsyCompletedNCT05875974Phase 4Results posted
- A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With NarcolepsyCompletedNCT05869773Phase 4Results posted
- Narcolepsy Nightmare StudyCompletedNCT05709873Not applicableResults posted
- A Study of TAK-861 in Participants With Narcolepsy Type 2CompletedNCT05687916Phase 2Results posted
- A Study of TAK-861 in Participants With Narcolepsy Type 1CompletedNCT05687903Phase 2Results posted
- A Study of TAK-994 in Adults With NarcolepsyTerminatedNCT04820842Phase 2Results posted
- An Interventional Safety Switch Study (Segue Study) of XYWAV in NarcolepsyCompletedNCT04794491Phase 4Results posted
- A Study to Collect Information of People With Narcolepsy in SpainCompletedNCT04667338Results posted
- Awareness and Self-Compassion Enhancing Narcolepsy TreatmentCompletedNCT04306952Not applicableResults posted
- Advancing Understanding of Transportation OptionsCompletedNCT04141891Not applicableResults posted
- A Study of TAK-994 in Adults With Type 1 and Type 2 NarcolepsyTerminatedNCT04096560Phase 2Results posted
- A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without CataplexyCompletedNCT04072380Phase 2Results posted
- Clarithromycin Mechanisms in Hypersomnia SyndromesCompletedNCT04026958Phase 2Results posted
- Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)CompletedNCT03881852Phase 2Results posted
- Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic HypersomniaCompletedNCT03772314Phase 2Results posted
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With NarcolepsyCompletedNCT03748979Phase 1Results posted
- Phase 1 TAK-925 Study in Healthy Adult and Elderly Volunteers and Participants With NarcolepsyCompletedNCT03332784Phase 1Results posted
- A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With CataplexyCompletedNCT03030599Phase 3Results posted
- Safety and Efficacy of THN102 on Sleepiness in Narcoleptic PatientsCompletedNCT02821715Phase 2Results posted
- Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in NarcolepsyCompletedNCT02806908Phase 2Results posted
- Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in NarcolepsyCompletedNCT02720744Phase 3Results posted
- Xyrem and Brain Dopamine in NarcolepsyCompletedNCT02637076Phase 4Results posted
- Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label PeriodCompletedNCT02611687Phase 3Results posted
- "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"CompletedNCT02348632Phase 3Results posted
- "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy"CompletedNCT02348593Phase 3Results posted
- A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With CataplexyCompletedNCT02221869Phase 3Results posted
- Sustainable Methods, Algorithms, and Research Tools for Delivering Optimal Care StudyCompletedNCT02037438Not applicableResults posted
- A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With NarcolepsyCompletedNCT01681121Phase 2Results posted
- A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime SleepinessCompletedNCT01485770Phase 2Results posted
- Risk of Narcolepsy Associated With Administration of H1N1 VaccineCompletedNCT01394614Results posted
- Flumazenil for the Treatment of Primary HypersomniaCompletedNCT01183312Phase 1/2Results posted
- Clarithromycin for the Treatment of HypersomniaCompletedNCT01146600Phase 2Results posted
- A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With NarcolepsyCompletedNCT01006122Phase 2Results posted
- Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine ChangesCompletedNCT00345800Phase 1Results posted
- Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea SyndromeCompletedNCT00228566Phase 3Results posted
- Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive SleepinessCompletedNCT00228553Phase 3Results posted
- Trial of Xyrem® (Sodium Oxybate) for the Treatment of NarcolepsyCompletedNCT00132873Phase 3Results posted
- Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With NarcolepsyCompletedNCT00078377Phase 3Results posted
- Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep DisorderCompletedNCT00078312Phase 3Results posted
- Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in NarcolepsyCompletedNCT00066170Phase 3Results posted
- Imagery Control Therapy and Lucid Dreaming for REM-Related Symptoms in NarcolepsyCompletedNCT07609537Not applicable
- A Trial of TAK-861 for the Treatment of Narcolepsy With CataplexyActive, not recruitingNCT07363720Phase 3
- A Study of HBS-201 (Pitolisant Delayed-release)CompletedNCT07051252Phase 1
- A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1TerminatedNCT06961266Phase 1
- Observational Study of LUMRYZ in NarcolepsyCompletedNCT06792708
- A Clinical Study of MK-6552 and Modafinil in Healthy Men (MK-6552-005)CompletedNCT06665230Phase 1
- A Study of MK-6552 in Sleep Deprived Healthy Participants (MK-6552-003)CompletedNCT06619665Phase 1
- Study of Psychological, Sociological and Professional Factors Associated With Maintenance of Wakefulness TestCompletedNCT06586138
- A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2CompletedNCT06555783Phase 2
- A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1CompletedNCT06462404Phase 1
- A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)CompletedNCT06358950Phase 2
- Transcutaneous Auricular Vagus Nerve Stimulation in Patients With Narcolepsy Type 1CompletedNCT06241911Not applicable
- Contribution of 7 Tesla MRI of the Hypothalamus in the Diagnosis of Type 1 NarcolepsyCompletedNCT05967832Not applicable
- Feasibility Study of At-Home EEG Monitoring for HypersomniaWithdrawnNCT05627388Not applicable
- Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With HypersomnolenceCompletedNCT05615584Not applicable
- Expanded Access to SUVN-G3031 (Samelisant) for the Treatment of Subjects With NarcolepsyNo longer availableNCT05530447
- Evaluation of the Effectiveness of a Physical Activity Program on the Severity of NarcolepsyCompletedNCT05460052
- Clinical and Neurophysiological Characteristics of NarcolepsyCompletedNCT05375890
- Development and Validation of Pediatric Narcolepsy Patient Reported Outcomes ScaleCompletedNCT05373979
- Group Psychotherapy in Narcolepsy Type 1CompletedNCT05314556Not applicable
- A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)CompletedNCT05113745Phase 3
- A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With NarcolepsyCompletedNCT05059223Phase 3
- An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With NarcolepsyCompletedNCT05055024Phase 2
- This is a Study to Determine the Effect of Multiple Doses of an Investigational Drug, Taken by Mouth, in People With Narcolepsy-cataplexy. Accepting Both Males and Females Ages of 18 Years to 55 Years. This Study Will be Conducted in the US and Will Require Approximately 13 Weeks Participation.CompletedNCT05015673Phase 1
- Evaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral AdministrationCompletedNCT05008341Phase 1
- Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of NarcolepsyCompletedNCT04923594Phase 2
- Child and Adolescent Registry for Participants With NarcolepsyStatus unknownNCT04899947